Partnerships built around human biology
LinkedIn caption
🤝 Partnerships built around human biology
What does a useful partnership in aging research need to bring to the table? Morten Sogaard addressed that question at ARDD 2026’s New Technology Partnering & Licensing panel, describing Astellas’ interest in individual drug assets, therapeutic platforms and AI collaborations.
💡 A priority in his contribution was access to high-quality human biology datasets. The wider panel linked partnership decisions to evidence in specific diseases, clear mechanisms and responsible handling of data and AI models. These requirements shape how a promising research platform becomes a development opportunity.
Sogaard also discussed active partnering in China. The panel considered the speed and quality of Chinese biotechnology alongside restrictions on exporting data and samples, highlighting practical considerations for cross-border scientific collaboration.
#ARDD2026 #Biotech
X caption
🤝 At #ARDD2026, Morten Sogaard discussed Astellas’ partnering across drug assets, platforms and AI, with high-quality human biology data a priority and cross-border collaboration part of the picture. Useful partnerships connect scientific strengths with development needs.
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
